Chapter/Section Purchase

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nucleic Acid Vaccine
1.2 Key Market Segments
1.2.1 Nucleic Acid Vaccine Segment by Type
1.2.2 Nucleic Acid Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Nucleic Acid Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Nucleic Acid Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Nucleic Acid Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Nucleic Acid Vaccine Market Competitive Landscape
3.1 Global Nucleic Acid Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Nucleic Acid Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Nucleic Acid Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nucleic Acid Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Nucleic Acid Vaccine Sales Sites, Area Served, Product Type
3.6 Nucleic Acid Vaccine Market Competitive Situation and Trends
3.6.1 Nucleic Acid Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nucleic Acid Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Nucleic Acid Vaccine Industry Chain Analysis
4.1 Nucleic Acid Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nucleic Acid Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Nucleic Acid Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nucleic Acid Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Nucleic Acid Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Nucleic Acid Vaccine Price by Type (2019-2024)
7 Nucleic Acid Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nucleic Acid Vaccine Market Sales by Application (2019-2024)
7.3 Global Nucleic Acid Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Nucleic Acid Vaccine Sales Growth Rate by Application (2019-2024)
8 Nucleic Acid Vaccine Market Segmentation by Region
8.1 Global Nucleic Acid Vaccine Sales by Region
8.1.1 Global Nucleic Acid Vaccine Sales by Region
8.1.2 Global Nucleic Acid Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Nucleic Acid Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nucleic Acid Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nucleic Acid Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nucleic Acid Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nucleic Acid Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Moderna
9.1.1 Moderna Nucleic Acid Vaccine Basic Information
9.1.2 Moderna Nucleic Acid Vaccine Product Overview
9.1.3 Moderna Nucleic Acid Vaccine Product Market Performance
9.1.4 Moderna Business Overview
9.1.5 Moderna Nucleic Acid Vaccine SWOT Analysis
9.1.6 Moderna Recent Developments
9.2 CureVac
9.2.1 CureVac Nucleic Acid Vaccine Basic Information
9.2.2 CureVac Nucleic Acid Vaccine Product Overview
9.2.3 CureVac Nucleic Acid Vaccine Product Market Performance
9.2.4 CureVac Business Overview
9.2.5 CureVac Nucleic Acid Vaccine SWOT Analysis
9.2.6 CureVac Recent Developments
9.3 Inovio
9.3.1 Inovio Nucleic Acid Vaccine Basic Information
9.3.2 Inovio Nucleic Acid Vaccine Product Overview
9.3.3 Inovio Nucleic Acid Vaccine Product Market Performance
9.3.4 Inovio Nucleic Acid Vaccine SWOT Analysis
9.3.5 Inovio Business Overview
9.3.6 Inovio Recent Developments
9.4 Sanofi
9.4.1 Sanofi Nucleic Acid Vaccine Basic Information
9.4.2 Sanofi Nucleic Acid Vaccine Product Overview
9.4.3 Sanofi Nucleic Acid Vaccine Product Market Performance
9.4.4 Sanofi Business Overview
9.4.5 Sanofi Recent Developments
9.5 GSK
9.5.1 GSK Nucleic Acid Vaccine Basic Information
9.5.2 GSK Nucleic Acid Vaccine Product Overview
9.5.3 GSK Nucleic Acid Vaccine Product Market Performance
9.5.4 GSK Business Overview
9.5.5 GSK Recent Developments
9.6 CNBG
9.6.1 CNBG Nucleic Acid Vaccine Basic Information
9.6.2 CNBG Nucleic Acid Vaccine Product Overview
9.6.3 CNBG Nucleic Acid Vaccine Product Market Performance
9.6.4 CNBG Business Overview
9.6.5 CNBG Recent Developments
9.7 Hualan Bio
9.7.1 Hualan Bio Nucleic Acid Vaccine Basic Information
9.7.2 Hualan Bio Nucleic Acid Vaccine Product Overview
9.7.3 Hualan Bio Nucleic Acid Vaccine Product Market Performance
9.7.4 Hualan Bio Business Overview
9.7.5 Hualan Bio Recent Developments
9.8 Zhifei Shengwu
9.8.1 Zhifei Shengwu Nucleic Acid Vaccine Basic Information
9.8.2 Zhifei Shengwu Nucleic Acid Vaccine Product Overview
9.8.3 Zhifei Shengwu Nucleic Acid Vaccine Product Market Performance
9.8.4 Zhifei Shengwu Business Overview
9.8.5 Zhifei Shengwu Recent Developments
9.9 Liaoning Chengda
9.9.1 Liaoning Chengda Nucleic Acid Vaccine Basic Information
9.9.2 Liaoning Chengda Nucleic Acid Vaccine Product Overview
9.9.3 Liaoning Chengda Nucleic Acid Vaccine Product Market Performance
9.9.4 Liaoning Chengda Business Overview
9.9.5 Liaoning Chengda Recent Developments
9.10 BioKangtai
9.10.1 BioKangtai Nucleic Acid Vaccine Basic Information
9.10.2 BioKangtai Nucleic Acid Vaccine Product Overview
9.10.3 BioKangtai Nucleic Acid Vaccine Product Market Performance
9.10.4 BioKangtai Business Overview
9.10.5 BioKangtai Recent Developments
9.11 CanSinoBIO
9.11.1 CanSinoBIO Nucleic Acid Vaccine Basic Information
9.11.2 CanSinoBIO Nucleic Acid Vaccine Product Overview
9.11.3 CanSinoBIO Nucleic Acid Vaccine Product Market Performance
9.11.4 CanSinoBIO Business Overview
9.11.5 CanSinoBIO Recent Developments
9.12 Walvax Biotechnology
9.12.1 Walvax Biotechnology Nucleic Acid Vaccine Basic Information
9.12.2 Walvax Biotechnology Nucleic Acid Vaccine Product Overview
9.12.3 Walvax Biotechnology Nucleic Acid Vaccine Product Market Performance
9.12.4 Walvax Biotechnology Business Overview
9.12.5 Walvax Biotechnology Recent Developments
9.13 Fosun Pharma
9.13.1 Fosun Pharma Nucleic Acid Vaccine Basic Information
9.13.2 Fosun Pharma Nucleic Acid Vaccine Product Overview
9.13.3 Fosun Pharma Nucleic Acid Vaccine Product Market Performance
9.13.4 Fosun Pharma Business Overview
9.13.5 Fosun Pharma Recent Developments
10 Nucleic Acid Vaccine Market Forecast by Region
10.1 Global Nucleic Acid Vaccine Market Size Forecast
10.2 Global Nucleic Acid Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Nucleic Acid Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Nucleic Acid Vaccine Market Size Forecast by Region
10.2.4 South America Nucleic Acid Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Nucleic Acid Vaccine by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Nucleic Acid Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Nucleic Acid Vaccine by Type (2025-2030)
11.1.2 Global Nucleic Acid Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Nucleic Acid Vaccine by Type (2025-2030)
11.2 Global Nucleic Acid Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Nucleic Acid Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Nucleic Acid Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings